Computerised brain implant reduces pain in NYU Langone’s study
The brain implant is said to be the first of its kind that targets chronic pain, which usually arises without a known trigger.
Neurology
Cala Health and UCSF to develop neuromodulation therapies
The technologies licenced from UCSF will boost Cala Health’s pipeline of neurology treatments.
Medtronic’s SenSight system for DBS gets FDA approval
The SenSight system can be used to treat symptoms linked to movement disorders such as...
Cognoa’s AI-based autism diagnosis aid gets FDA de novo clearance
Canvas Dx can be used by physicians for autism diagnosis in children aged 18 months...
Akili raises $160m to market cognitive disorder treatment for children
Akili Interactive raises $160m to commercialise its EndeavorRx video game treatment.
MedRhythms and EVERSANA to launch software-based device for stroke
MedRhythms and EVERSANA collaborate to market MR-001 for treating chronic stroke walking impairments.
Biocept initiates full sales force launch of cerebrospinal fluid assay
Biocept has initiated the full commercial launch of CNSide, its cerebrospinal fluid (CSF) assay that helps identify and manage the treatment of metastatic cancers involving the central nervous system (CNS).
FDA approves Cerus Endovascular’s application for Contour system study
The US Food and Drug Administration (FDA) has approved Cerus Endovascular’s investigational device exemption (IDE) application to carry out a trial of its Contour Neurovascular System in the country.
Feinstein Institutes develop implant model for VNS
Scientists at the Institute of Bioelectronic Medicine at The Feinstein Institutes for Medical Research have developed a long-term nerve implant model for bioelectronic medicine research.
Medicine music: how an earbud could treat arthritis and migraines
Nēsos has developed an earbud designed to deliver electrical field therapy to help treat inflammatory conditions like arthritis and migraines. Natalie Healey takes a closer look at the emerging technology and speaks to co-founder Konstantinos...
FDA authorises Helius’ neuromodulation stimulator for gait improvement
The US Food and Drug Administration (FDA) has authorised the marketing of Helius Medical’s Portable Neuromodulation Stimulator (PoNS) as a short-term treatment for adults with gait deficit from mild to moderate multiple sclerosis (MS).
